Skip to main content
Grant Details

Grant Number: 5U01CA062912-08 Interpret this number
Primary Investigator: Herbst, Arthur
Organization: University Of Chicago
Project Title: Des Assoc Cca of Vagina/Cervix--collaborative Studies
Fiscal Year: 2002
Back to top


Abstract

The data collected and analyzed in the Registry provide the sole comprehensive series of cases of DES-associated clear cell adenocarcinoma (CCA) of the vagina and/or cervix in women born after 1948 for comparative and collaborative study. Both DES-exposed and unexposed patients are accessioned. The Tissue Bank of fixed specimens from patients treated for CCA along with fresh tissue from newly diagnosed and/or recurrent cases will be maintained and expanded. An established Advisory Board of external investigators will meet regularly with to oversee the distribution of these rare tissues to qualified investigators for molecular studies. The success of these initial efforts has led to a new collaborative project with Dr. G. Cunha of UCSF, who, using fresh CCA tissue supplied by Registry patients, has established a human CCA transplant cell line. His laboratory will evaluate growth and differentiation requirements of CCA as well as identify the role of the stroma in these processes and test the response of CCA to estrogen with the goals of gaining a better understanding of the molecular regulations of these malignancies and the potential development of new therapeutic strategies. Collaborative work regarding the induction of microsatellite instability and down-regulation of DNA mismatch repair gene expression with Dr. Jeff Boyd, of MKSCC, is also being proposed. The hypothesis is that the induction of microsatellite instability represents a critical component of the molecular mechanism through which DES initiates carcinogenesis. Preliminary data indicate there may be a secondary rise in the age incidence curve developing in DES-exposed patients over the age of 40 years, similar to what is observed in the unexposed population. The possible early detection of such a rise will be tested. If detected, this would provide important public health information to the DES-exposed population since many physicians have erroneously assumed that patients over age 30 years are not at risk for CCA. With Dr. J. Palmer of the Boston University School of Medicine, epidemiologic studies will be performed to evaluate factors that contribute to the development of the disease in older DES-exposed (over age 35 years) and also the reasons for late recurrences of CCA (beyond 5 years).

Back to top


Publications

Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma.
Authors: Palmer J.R. , Anderson D. , Helmrich S.P. , Herbst A.L. .
Source: Obstetrics and gynecology, 2000 Jun; 95(6 Pt 1), p. 814-20.
PMID: 10831973
Related Citations

Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES).
Authors: Herbst A.L. .
Source: Gynecologic oncology, 2000 Feb; 76(2), p. 147-56.
PMID: 10637063
Related Citations

Bcl-2 protein expression associated with resistance to apoptosis in clear cell adenocarcinomas of the vagina and cervix expressing wild-type p53.
Authors: Waggoner S.E. , Baunoch D.A. , Anderson S.A. , Leigh F. , Zagaja V.G. .
Source: Annals of surgical oncology, 1998 Sep; 5(6), p. 544-7.
PMID: 9754764
Related Citations

p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix.
Authors: Waggoner S.E. , Anderson S.M. , Luce M.C. , Takahashi H. , Boyd J. .
Source: Gynecologic oncology, 1996 Mar; 60(3), p. 339-44.
PMID: 8774636
Related Citations

Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
Authors: Waggoner S.E. , Mittendorf R. , Biney N. , Anderson D. , Herbst A.L. .
Source: Gynecologic oncology, 1994 Nov; 55(2), p. 238-44.
PMID: 7959291
Related Citations




Back to Top